Healthscope Limited operates in the General medical & surgical hospitals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Healthscope Limited with three other
health care providers in Australasia:
Asian American Medical Group Ltd
sales of 17.07 million Australian Dollars [US$12.29 million]
(1.74 billion Australian Dollars [US$1.25 billion]
of which 63%
was Pathology), and
Pacific Smiles Group Ltd
(104.53 million Australian Dollars [US$75.25 million]
Healthscope Limited reported sales of A$2.34 billion (US$1.69 billion)
June of 2018.
a very small
increase of 1.0%
versus 2017, when the company's sales were A$2.32 billion.
This was the third consecutive year of growth at Healthscope Limited.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Healthscope Limited had sales
of A$2.21 billion.
Sales of Hospitals Australia saw an increase
that was more than double the company's growth rate: sales were up
4.3% in 2018, from
A$2.01 billion to A$2.10 billion.
Not all segments of Healthscope Limited experienced an increase in sales in 2018:
sales of Pathology New Zealand fell 0.9% to A$240.20 million.